NCCN Unveils Evidence Blocks As Part of Oncology Guidelines

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

The National Comprehensive Cancer Network unveiled a new initiative—NCCN Evidence Blocks—in the new versions of the NCCN Clinical Practice Guidelines in Oncology for Chronic Myelogenous Leukemia and Multiple Myeloma.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe

YOU MAY BE INTERESTED IN

Dennis Slamon, an oncologist and researcher at the UCLA Health Jonsson Comprehensive Cancer Center, and Tony Hunter, American Cancer Society Professor and Renato Dulbecco Chair at Salk Institute for Biological Studies, have been awarded the 2026 Albany Prize in Medicine and Biomedical Research. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login